These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway. Liu W; Zhang J; Yao X; Jiang C; Ni P; Cheng L; Liu J; Ni S; Chen Q; Li Q; Zhou K; Wang G; Zhou F Cancer Sci; 2018 Oct; 109(10):3294-3304. PubMed ID: 30151975 [TBL] [Abstract][Full Text] [Related]
10. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Schiffelers RM; Metselaar JM; Fens MH; Janssen AP; Molema G; Storm G Neoplasia; 2005 Feb; 7(2):118-27. PubMed ID: 15802017 [TBL] [Abstract][Full Text] [Related]
11. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro. Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578 [TBL] [Abstract][Full Text] [Related]
12. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma. Nik ME; Malaekeh-Nikouei B; Amin M; Hatamipour M; Teymouri M; Sadeghnia HR; Iranshahi M; Jaafari MR Sci Rep; 2019 Jul; 9(1):9527. PubMed ID: 31267009 [TBL] [Abstract][Full Text] [Related]
13. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma. Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity. Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819 [TBL] [Abstract][Full Text] [Related]
15. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer. Sen K; Banerjee S; Mandal M Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. Banciu M; Metselaar JM; Schiffelers RM; Storm G Neoplasia; 2008 Feb; 10(2):108-17. PubMed ID: 18283332 [TBL] [Abstract][Full Text] [Related]
18. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo. Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649 [TBL] [Abstract][Full Text] [Related]
19. Synergistic therapeutic effects of Schiff's base cross-linked injectable hydrogels for local co-delivery of metformin and 5-fluorouracil in a mouse colon carcinoma model. Wu X; He C; Wu Y; Chen X Biomaterials; 2016 Jan; 75():148-162. PubMed ID: 26497429 [TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts. Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul MM Anticancer Res; 2001; 21(5):3175-84. PubMed ID: 11848470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]